Skip to content

13F-HR filed by Camber Capital Management LP

Camber Capital Management LP filed this 13F-HR for the quarter ended 2019-09-30, filed 2019-11-14, with 34 holding rows worth $1,901,654,000.

Accession
0001654954-19-012910
Filed
2019-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2019

A holdings report, 34 entries on the cover page, a total value of $1,901,654,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,901,654,000 with VALUE read as thousands by filing date, 13F file number 028-13745. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ALLERGAN PLCG0177J108SHS1,000,000$168,290,000thousands by filing date
MYLAN NVN59465109SHS EURO8,500,000$168,130,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock1,700,000$95,013,000thousands by filing date
BROOKDALE SR LIVING INC112463104COM12,500,000$94,750,000thousands by filing date
DAVITA INC COM23918K108Stock1,500,000$85,605,000thousands by filing date
ALLERGAN PLCG0177J108SHS500,000$84,145,000thousands by filing datecall
ALEXION PHARMACEUTICALS INC015351109COM850,000$83,249,000thousands by filing date
BIOGEN INC COM09062X103Stock350,000$81,487,000thousands by filing date
Bristol-Myers Squibb Company110122108COM1,500,000$76,065,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock500,000$74,375,000thousands by filing date
HCA Healthcare Inc40412C101COM600,000$72,252,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock3,150,000$69,678,000thousands by filing date
ALKERMES PLCG01767105SHS3,500,000$68,285,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR650,000$62,608,000thousands by filing date
MYLAN NVN59465109SHS EURO3,000,000$59,340,000thousands by filing datecall
SAREPTA THERAPEUTICS INC803607100COM750,000$56,490,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM3,000,000$54,645,000thousands by filing date
AMAG PHARMACEUTICALS INC00163U106COM4,390,000$50,705,000thousands by filing date
MOMENTA PHARMACEUTICALS INC60877T100COM3,500,000$45,360,000thousands by filing date
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock2,950,000$41,654,000thousands by filing date
AbbVie,Inc.00287Y109COM500,000$37,860,000thousands by filing date
ZYMEWORKS INC98985W102COM1,500,000$37,200,000thousands by filing date
NOVO-NORDISK A S ADR670100205ADR700,000$36,190,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock400,000$31,900,000thousands by filing date
SYNTHORX INC COM87167A103Stock1,862,116$30,297,000thousands by filing date
MYRIAD GENETICS INC62855J104COM1,000,000$28,630,000thousands by filing date
CYCLERION THERAPEUTICS INC23255M105COM2,227,052$26,992,000thousands by filing date
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR500,000$21,340,000thousands by filing date
WRIGHT MED GROUP N VN96617118ORD SHS750,000$15,473,000thousands by filing date
GLYCOMIMETICS INC38000Q102COM3,500,000$15,085,000thousands by filing date
TRANSLATE BIO INC.89374L104Common Stock1,500,000$14,865,000thousands by filing date
TECTONIC THERAPEUTIC INC COM05455M100Stock500,000$7,060,000thousands by filing date
SUTRO BIOPHARMA INC869367102COM600,000$5,454,000thousands by filing date
SURGERY PARTNERS INC86881A100COM160,084$1,182,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001654954-19-012910this filing2019-11-14acceptance time not in the bulk data set